Literature DB >> 29551422

Incidence, Risk Factors, and Management of Blindness after Orbital Surgery.

Sarah M Jacobs1, Colin P McInnis2, Matthew Kapeles3, Shu-Hong Chang4.   

Abstract

PURPOSE: Severe vision loss is a risk of orbital surgery which physicians should counsel patients about, but the overall risk rate is unknown. This research was conducted to determine the risk of severe vision loss related to orbital surgery.
DESIGN: Retrospective review. PARTICIPANTS: Patients who underwent orbital surgery at either of 2 academic medical centers between January 1994 and December 2014.
METHODS: A billing database search was conducted to identify all patients who had orbital surgery during the study period, cross-checked against diagnostic codes related to vision loss. Charts were screened to determine baseline demographic and medical history, surgical procedure, intraoperative and perioperative management, and visual acuity. Patients with preoperative visual acuity ≥20/200 that worsened ≤20/400 after orbital surgery were included for detailed review. Statistical analysis was conducted to identify factors posing particular risk or benefit to visual outcome in these patients. MAIN OUTCOME MEASURES: Visual acuity after orbital surgery.
RESULTS: A total of 1665 patients underwent orbital surgery during the inclusion period, with 14 patients sustaining severe vision loss ranging from counting fingers at 1 foot to no light perception (overall risk, 0.84%). The causes of vision loss included retrobulbar hemorrhage, malpositioned implant, optic nerve ischemia, or direct optic nerve insult. When stratified by surgical approach, the risk of a blinding surgical complication was significantly higher for patients undergoing orbital floor repair in the setting of multiple facial fractures (subgroup risk, 6.45%), bony decompression of the optic canal (subgroup risk, 15.6%), or intracranial approach to the orbital roof (subgroup risk, 18.2%). Seven of 8 patients with a potentially reversible cause of postoperative vision loss underwent urgent repeat surgery, and 2 regained substantial vision (20/20 and 20/25). Administration of intravenous corticosteroids had no significant effect on visual acuity outcome.
CONCLUSIONS: The overall risk of severe vision loss after orbital surgery is 0.84%. The subgroup risk is higher in patients undergoing facial polytrauma repair, optic canal decompression, or orbital apex surgery from an intracranial approach. Close postoperative monitoring and urgent assessment and management of acute vision loss may improve visual outcome in some patients.
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29551422     DOI: 10.1016/j.ophtha.2018.01.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Transconjunctival and Transcaruncular Approaches to the Orbit.

Authors:  Natalie Wolkow; Suzanne K Freitag
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-09

2.  Principles of Protection of the Eye and Vision in Orbital Surgery.

Authors:  Jenny C Dohlman; Michael K Yoon
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-07

3.  A Case of Multi-System Langerhans Cell Histiocytosis with Local Invasion of the Orbital Apex.

Authors:  Hiroko Yamada; Takuji Kurimoto; Sotaro Mori; Mari Sakamoto; Kaori Ueda; Yuko Yamada-Nakanishi; Yoichi Uozumi; Hiroyasu Shose; Masaaki Taniguchi; Masanori Toyoda; Hironobu Minami; Makoto Nakamura
Journal:  Case Rep Ophthalmol       Date:  2019-09-19

4.  Incidence and management of retrobulbar hemorrhage after blowout fracture repair.

Authors:  Jae Hwi Park; Inhye Kim; Jun Hyuk Son
Journal:  BMC Ophthalmol       Date:  2021-04-22       Impact factor: 2.209

Review 5.  Perioperative Considerations for Antithrombotic Therapy in Oculofacial Surgery: A Review of Current Evidence and Practice Guidelines.

Authors:  Christian Kim; Margaret L Pfeiffer; Jessica R Chang; Michael A Burnstine
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2022-01-11       Impact factor: 2.011

Review 6.  Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.

Authors:  Mizuki Tagami; Shigeru Honda; Atsushi Azumi
Journal:  Clin Ophthalmol       Date:  2022-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.